J&J targets 2024 for Ottava FDA filing
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson & Johnson on Tuesday
November 7, 2023
Menu
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson & Johnson on Tuesday
Red Light Holland’s psilocybin capsules successfully passed an 8-week stability test, paving the way for medical distribution in Australia, where the drug has been reclassified
To build or to buy? That’s a classic question for pharma boardrooms, and Novo Nordisk is going with both. Beyond spending billions of dollars to